Special properties of pneumococci affect their ability to cause meningitis

by Karolinska InstitutetCredit: AI-generated imageStructures on the surface of pneumococci determine the ability of these bacteria to enter the brain and cause severe infections, according to a p

Updated on: March 06,2024

Special properties of pneumococci affect their ability to cause meningitis

by Karolinska InstitutetCredit: AI-generated imageStructures on the surface of pneumococci determine the ability of these bacteria to enter the brain and cause severe infections, according to a p

Updated on:March 06,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on: March 13,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on:March 13,2024

Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on: February 26,2024

Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on:February 26,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on: May 06,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on:May 06,2024

Neuroscientists explore how the brain makes decisions

byHarvard Medical SchoolCredit: Pixabay/CC0 Public DomainScientists have gained new insights into how neurons in the brain communicate during a decision, and how the connections between neurons

Updated on: March 13,2024

Neuroscientists explore how the brain makes decisions

byHarvard Medical SchoolCredit: Pixabay/CC0 Public DomainScientists have gained new insights into how neurons in the brain communicate during a decision, and how the connections between neurons

Updated on:March 13,2024

AAN recommends people 65+ be screened yearly for memory problems

by American Academy of NeurologyCredit: Public DomainPeople with mild cognitive impairment have thinking and memory problems but usually do not know it because such problems are not severe enough

Updated on: March 19,2024

AAN recommends people 65+ be screened yearly for memory problems

by American Academy of NeurologyCredit: Public DomainPeople with mild cognitive impairment have thinking and memory problems but usually do not know it because such problems are not severe enough

Updated on:March 19,2024

Partially sighted may be at higher risk of dementia

by Anglia Ruskin UniversityCredit: CC0 Public DomainOlder people with vision loss are significantly more likely to suffer mild cognitive impairment, which can be a precursor to dementia, accordin

Updated on: May 05,2024

Partially sighted may be at higher risk of dementia

by Anglia Ruskin UniversityCredit: CC0 Public DomainOlder people with vision loss are significantly more likely to suffer mild cognitive impairment, which can be a precursor to dementia, accordin

Updated on:May 05,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on: March 09,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on:March 09,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on: September 23,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on:September 23,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on: March 02,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on:March 02,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on: June 14,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on:June 14,2024